ImmunityBio (IBRX) Other Accumulated Expenses (2014 - 2026)
ImmunityBio (IBRX) reported Other Accumulated Expenses of $2.45 million for Q1 2026, down 7.6% from $2.65 million a year earlier and down 20.3% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Other Accumulated Expenses (2014 - 2026) Analysis & Trends
At the end of FY2025, ImmunityBio posted Other Accumulated Expenses of $3.07 million, up 192.7% from FY2024.
- Other Accumulated Expenses has a five-year compound annual growth rate of -27.0% (FY2020 to FY2025).
- By year, Other Accumulated Expenses came in at $1.05 million in FY2024 (+46.6%), $716,000 in FY2023 (-56.0%), $1.63 million in FY2022 (-58.7%) and $3.94 million in FY2021 (-73.4%).
- Five-year quarterly Other Accumulated Expenses spans a low of $556,000 in Q1 2024 and a high of $5.6 million in Q1 2022.
- Year over year, Other Accumulated Expenses gained in six of the last eight quarters, with growth averaging 106.5%.
- The high point for year-over-year Other Accumulated Expenses in five years was Q3 2022 (growth of 408.1%); the low point was Q1 2024 (a decline of 81.0%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $3.07 million (Q4 2025), $2.12 million (Q3 2025) and $1.94 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | ImmunityBio | 10.83 Bn | 9.59 Bn | 50.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2.45 Mn |
| Dec 31, 2025 | 3.07 Mn |
| Sep 30, 2025 | 2.12 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Mar 31, 2025 | 2.65 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.41 Mn |
| Jun 30, 2024 | 692,000.00 |
| Mar 31, 2024 | 556,000.00 |
| Dec 31, 2023 | 716,000.00 |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 818,000.00 |
| Mar 31, 2023 | 2.93 Mn |
| Dec 31, 2022 | 1.63 Mn |
| Sep 30, 2022 | 3.02 Mn |
| Jun 30, 2022 | 4.16 Mn |
| Mar 31, 2022 | 5.60 Mn |
| Dec 31, 2021 | 3.94 Mn |
| Sep 30, 2021 | 594,000.00 |
| Dec 31, 2020 | 14.84 Mn |
API Access
ImmunityBio Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();